Literature DB >> 24764358

Trimeric knob protein specifically distinguishes neutralizing antibodies to different human adenovirus species: potential application for adenovirus seroepidemiology.

Bin Yu1,2, Jianing Dong2, Chu Wang2, Zhen Wang2, Lei Gao2, Haihong Zhang1,2, Jiaxin Wu1,2, Wei Kong1,2, Xianghui Yu1,2.   

Abstract

Adenoviruses (Ads) are non-enveloped DNA viruses that have been extensively studied and used as vectors for gene therapy and several potential vaccines. There are 57 Ad serotypes in seven species (A-G), and Ad neutralizing antibody (NAb) titres can vary by serotype and geographical location. Until now serotype- and species-specific antibodies have been detected by neutralization or haemagglutination inhibition assays. These expensive and cumbersome methods of adenovirus typing have mainly been used in epidemiological studies. Our prior work demonstrated that NAbs against the fiber protein are commonly generated during natural Ad infection in humans and the trimeric knob is preferentially recognized by fiber-induced NAbs. In this study, we expressed nine trimeric knob proteins from representative Ad serotypes of human Ad (HAdV)-A-F in Escherichia coli and found no cross-reactivity of these recombinant proteins with rabbit hyperimmune sera (among HAdV-A-F or within HAdV-C). Results of the ELISA based on Ad2 and Ad5 (both HAdV-C) knob proteins were consistent with those of neutralization assays, indicating that the trimeric knob protein would be a good candidate antigen for detecting Ad serotype-specific NAbs in sera from naturally infected subjects. We also demonstrated the primary seroepidemiology of nine Ad serotypes in 274 children using the knob-based ELISA. These results have potential implications for epidemiology of Ad serotypes and future development of Ad-based vaccines and gene therapy.
© 2014 The Authors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24764358     DOI: 10.1099/vir.0.064832-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

Review 1.  Vaccine development for human mastadenovirus.

Authors:  Shiying Chen; Xingui Tian
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Oncolytic Adenovirus-Loaded Menstrual Blood Stem Cells Overcome the Blockade of Viral Activity Exerted by Ovarian Cancer Ascites.

Authors:  Ana Laura Alfano; Alejandro Nicola Candia; Nicasio Cuneo; Leandro N Guttlein; Alejandro Soderini; Cecilia Rotondaro; Leonardo Sganga; Osvaldo L Podhajcer; M Veronica Lopez
Journal:  Mol Ther Oncolytics       Date:  2017-06-16       Impact factor: 7.200

3.  Rapid Construction of a Replication-Competent Infectious Clone of Human Adenovirus Type 14 by Gibson Assembly.

Authors:  Haibin Pan; Yuqian Yan; Jing Zhang; Shan Zhao; Liqiang Feng; Junxian Ou; Na Cao; Min Li; Wei Zhao; Chengsong Wan; Ashrafali M Ismail; Jaya Rajaiya; James Chodosh; Qiwei Zhang
Journal:  Viruses       Date:  2018-10-18       Impact factor: 5.048

4.  Adenovirus-mediated small interfering RNA targeting ezrin induces apoptosis and inhibits metastasis of human osteosarcoma MG-63 cells.

Authors:  Zhi-Wei Tao; Ping-An Zou
Journal:  Biosci Rep       Date:  2018-08-29       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.